(Q70589402)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6469495%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

title

Phase I and pharmacologic evaluation of nafazatrom in patients with cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6469495%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

author name string

C D Haas

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6469495%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

L H Baker

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6469495%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

L J Evans

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6469495%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

publication date

1 January 1984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6469495%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

12 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6469495%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6469495%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6469495%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

page(s)

13-17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6469495%20AND%20SRC:MED&resulttype=core&format=json

The antithrombotic activity of BAY g 6575

12 October 2019

cites work

1 reference

12 December 2020

High-performance liquid chromatographic determination of nafazatrom in human plasma using fluorescence detection

1 reference

12 December 2020

Stimulation of prostacyclin release from vessel wall by Bay g 6575, an antithrombotic compound

1 reference

12 December 2020

Prostacyclin: a potent antimetastatic agent

1 reference

12 December 2020

Control of tumor growth and metastasis with prostacyclin and thromboxane synthetase inhibitors: evidence for a new antitumor and antimetastatic agent (BAY g 6575).

1 reference

12 December 2020

Nafazatrom (Bay g 6575) inhibition of tumor cell lipoxygenase activity and cellular proliferation

1 reference

12 December 2020

Identifiers

1 reference